Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Return on Sales: 2011-2025

Historic Return on Sales for ProPhase Labs (PRPH) over the last 15 years, with Sep 2025 value amounting to -0.66%.

  • ProPhase Labs' Return on Sales fell 1938.00% to -0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.66%, marking a year-over-year decrease of 1938.00%. This contributed to the annual value of -0.56% for FY2024, which is 55.00% down from last year.
  • According to the latest figures from Q3 2025, ProPhase Labs' Return on Sales is -0.66%, which was down 298.41% from 0.33% recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Return on Sales registered a high of 18.72% during Q3 2024, and its lowest value of -2.35% during Q2 2024.
  • For the 3-year period, ProPhase Labs' Return on Sales averaged around 1.35%, with its median value being -0.17% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 1,889bps in 2024, then tumbled by 1,938bps in 2025.
  • Quarterly analysis of 5 years shows ProPhase Labs' Return on Sales stood at 0.07% in 2021, then grew by 8bps to 0.15% in 2022, then plummeted by 62bps to -0.47% in 2023, then dropped by 10bps to -0.56% in 2024, then slumped by 1,938bps to -0.66% in 2025.
  • Its Return on Sales was -0.66% in Q3 2025, compared to 0.33% in Q2 2025 and 0.96% in Q1 2025.